Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults (Q34009363)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults |
scientific article |
Statements
1 reference
Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults (English)
1 reference
Etienne M Sokal
1 reference
Karel Hoppenbrouwers
1 reference
Corinne Vandermeulen
1 reference
Michel Moutschen
1 reference
Philippe Léonard
1 reference
Andre Moreels
1 reference
Michèle Haumont
1 reference
Alex Bollen
1 reference
Françoise Smets
1 reference
Martine Denis
1 reference
1 December 2007
1 reference
1 reference
196
1 reference
12
1 reference
1749-1753
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference